Galligan Andrew H 4
4 · NEVRO CORP · Filed Mar 3, 2020
Insider Transaction Report
Form 4
NEVRO CORPNVRO
Galligan Andrew H
VP of Finance , CFO
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2020-02-28−8,000→ 33,394 totalExercise: $3.60Exp: 2021-09-28→ Common Stock (8,000 underlying) - Exercise/Conversion
Common Stock
2020-02-28$3.60/sh+8,000$28,800→ 61,490 total
Footnotes (2)
- [F1]Includes 16,773 restricted stock units.
- [F2]Fully vested.